WEBVTT

1
00:00:01.300 --> 00:00:08.032
This is Anthropic, Read Aloud. Today: Introducing the Life Sciences Verification Program.

2
00:00:09.332 --> 00:00:12.527
Introducing the Life Sciences Verification Program.

3
00:00:12.977 --> 00:00:20.721
Anthropic is an A I safety and research company that's working to build reliable, interpretable, and steerable A I systems.

4
00:00:21.171 --> 00:00:25.905
From Anthropic Newsroom, published September 17, 2026.

5
00:00:26.905 --> 00:00:42.181
Today, we are introducing the Life Sciences Verification Program (LSVP), which gives life science professionals access to our Mythos, Opus, and Sonnet models with a refined set of safeguards more permissive for biology-related work.

6
00:00:42.301 --> 00:01:03.484
We have already onboarded dozens of organizations through an early access program, and are now opening applications to the broader life science community ( apply here ). The program is launching in beta, initially for teams and institutions. We will continue to improve the program and expand access to individual Pro and Max plans over time.

7
00:01:03.934 --> 00:01:25.453
The LSVP is designed to enable life science professionals to use our models across a wide range of tasks that are currently blocked in our generally-available Fable models, like drug discovery, research biology, clinical development, and manufacturing. It’s built for teams of all kinds, from academic labs to startups, pharma companies, and more.

8
00:01:26.253 --> 00:01:28.165
Verification and access types.

9
00:01:28.615 --> 00:01:48.561
To qualify for these grants, each applicant goes through a verification process that includes a review of their research credentials, security standards, and ethical research oversight. Once verified, teams may apply for two types of LSVP grants, “Standard Use” or “High-risk Use,” depending on their access needs.

10
00:01:48.681 --> 00:02:10.666
These grants can be used through all our product surfaces, including Claude Science, Claude.ai, Claude Code and the A P I. Standard Use grants are suitable for most life science work, including the majority of biology research and development workflows. These grants can be extended to entire teams for diverse, daily workloads, and are renewed once a year.

11
00:02:10.786 --> 00:02:29.218
They give those teams access to our Mythos, Opus, and Sonnet models, with refined classifiers that are more permissive for science tasks than our generally-available models. Standard Use grants apply to Mythos 5.1, Opus 5 and Sonnet 5 today, and to future models as they launch.

12
00:02:29.338 --> 00:02:45.358
They’re specifically designed to enable the full breadth of life science activities in areas spanning basic science, R and D, supply chain and manufacturing, clinical development, quality assurance, regulatory affairs, investing and diligence, and more.

13
00:02:45.808 --> 00:02:55.131
Although we expect Standard Use to cover the majority of access needs, some work carries a higher potential for misuse and therefore requires additional vetting.

14
00:02:55.581 --> 00:03:12.178
High-risk Use is an add-on grant for teams working in areas blocked under Standard Use. It removes all safeguards that block life sciences requests. This grant applies to a single research project as opposed to a full team, and must be renewed every six months.

15
00:03:12.298 --> 00:03:32.991
Typically, a single researcher with dual-use work would have access to one Standard Use grant for diverse, daily activities, and one or more High-risk Use grants which only apply to work on specific projects (for example, characterizing how one specific family of viral vectors is recognized by human immune pathways).

16
00:03:33.441 --> 00:03:50.674
High-risk grants for Claude Opus 5 and Claude Sonnet 5 are available today. We are working with the U S government to make high-risk grants more broadly available for Claude Mythos, but at the time of this launch they will remain limited to a small set of entities with additional vetting.

17
00:03:51.124 --> 00:03:56.969
All other safeguards, such as cyber classifiers, will remain in place under LSVP grants.

18
00:03:57.769 --> 00:04:00.906
Enabling trusted access through shared responsibility.

19
00:04:01.356 --> 00:04:12.684
As we’ve shown in our recent threat report, there are increasingly sophisticated misuse attempts happening on our platform, including attempts that could support biological weapons development.

20
00:04:12.804 --> 00:04:28.957
In biology, where it’s often not possible to differentiate between a user doing valid work (for example, research a viral pathogen to develop vaccines against it) and pursuing harm (for example, trying to increase the transmissibility of a virus maliciously),

21
00:04:29.077 --> 00:04:36.842
the most concerning threat models are ones where valid access has been diverted or overtaken by an actor with bad intent.

22
00:04:36.962 --> 00:04:51.244
Indeed, insider threats and rogue-use have been major factors in significant biosafety incidents and scares. In developing the LSVP’s safeguards, we aimed to protect against three concerning threat models in particular:

23
00:04:51.694 --> 00:04:57.039
Access compromise: Malware or account takeover diverting access to a bad actor.

24
00:04:57.279 --> 00:05:05.527
Insider threats: Rogue or coerced employees intentionally taking malicious action or diverting their access to a bad actor.

25
00:05:05.767 --> 00:05:13.950
Agent misuse: Agents, especially working in swarms or over long-horizon tasks, taking unintended dangerous actions.

26
00:05:14.400 --> 00:05:29.526
In order to defend against these threats and in close collaboration with enterprise CISOs, we designed the new LSVP safeguards around the concept of shared responsibility by monitoring usage against the intended use-case for the model access.

27
00:05:29.646 --> 00:05:42.766
Because we vet the LSVP organizations for their life sciences credibility and oversight, we can empower them to specify for themselves what constitutes safe usage for teams or projects within their program.

28
00:05:43.216 --> 00:06:07.011
Each entity’s access is tied to the use cases it has specified in its grant applications, and we continuously monitor LSVP traffic to identify usage or patterns which are outside the stated safe scope. Should unauthorized activity occur, we can flag these cases to organization admins to take action within pre-agreed timeframes for triaging and remediating incidents.

29
00:06:07.131 --> 00:06:16.920
The use cases should include high-level descriptions of the intended work, like one would share in a job listing, and not include any sensitive information or IP.

30
00:06:17.720 --> 00:06:19.915
How monitoring works in LSVP.

31
00:06:20.365 --> 00:06:42.857
Serious misuse is often spread across many requests and sessions to look disconnected and evade detection. In the LSVP, we are shifting safeguards from real-time blocking, where we reject potentially harmful access at the time of each request, to offline monitoring, which allows us to more clearly identify potential misuse across patterns of behavior.

32
00:06:42.977 --> 00:07:03.361
Shifting enforcement from real-time blocking to offline monitoring allows legitimate work to proceed with fewer interruptions, but it requires us to retain data associated with flagged activity for review. For LSVP traffic, we are requiring data retention for 30 days to be able to do this monitoring effectively.

33
00:07:03.811 --> 00:07:23.320
This data is strictly compartmentalized and cannot be used for model training or accessed by members of Anthropic’s life sciences research teams. For organizations that qualify, we are also working to understand how LSVP can integrate with features from our Enterprise Frontier Safeguards (EFS) systems.

34
00:07:24.120 --> 00:07:25.523
What researchers are saying.

35
00:07:25.973 --> 00:07:41.695
Quote: Xaira is making biology more computable, generating biological data at unprecedented scale and building foundation models of cell, protein and disease biology that turn it into the next generation of life-changing medicines.

36
00:07:41.815 --> 00:07:56.527
We’re excited to put Anthropic's frontier models to work across our drug discovery engine, and we believe pairing trusted access with intelligence is the right way to realize A I’s promise in biology.Xaira Therapeutics. End quote.

37
00:07:56.977 --> 00:08:20.067
Quote: Edison’s mission is to accelerate science and the discovery and development of new medicines. With the Life Sciences Verification Program, we are excited to be able to bring Anthropic’s most intelligent models to bear on these problems. We look forward to collaborating with Anthropic further to end disease and improve the lives of patients everywhere.Edison Scientific.

38
00:08:20.187 --> 00:08:21.013
End quote.

39
00:08:21.463 --> 00:08:41.379
Quote: At Manifold Bio, we’re building a massively parallel interface into living systems to enable powerful A I to create medicines. We look forward to putting frontier intelligence to work safely in our engine, and we welcome Anthropic’s approach of pairing access with accountability.Manifold Bio. End quote.

40
00:08:41.829 --> 00:08:43.655
01 / 03

41
00:08:44.455 --> 00:08:46.456
Applications and availability.

42
00:08:46.906 --> 00:09:02.575
Organizations interested in joining the LSVP can submit an application here. We expect to enroll hundreds of organizations within the first week, and to scale the program further to support the majority of the life science community in the coming weeks.

43
00:09:03.025 --> 00:09:20.726
Today, LSVP is available in our first party console for A P I usage, as well as in Claude for Enterprise and Team plans. We do not yet support individual plans but are working to expand access for these users. It is also not yet available on third-party platforms.

44
00:09:21.176 --> 00:09:31.852
As a beta, LSVP is not available for BAA-enabled orgs. This means customers with PHI data should use separate non-BAA orgs with non-HIPAA.

45
00:09:32.302 --> 00:09:52.603
In A P I and Claude Science, users can switch between grants natively. In Claude.ai and Claude Code, initially only a preselected default grant applies (except while using Claude Code with A P I authentication). This should be fine for the vast majority of users, who will only ever require a Standard Use grant.

46
00:09:52.723 --> 00:09:58.003
However, we will improve support and portability of these LSVP features over time.

47
00:09:58.803 --> 00:09:59.841
What comes next.

48
00:10:00.291 --> 00:10:18.126
Providing these frontier capabilities is part of our broader efforts in supporting the life sciences community in our shared mission to accelerate curing disease and improving human health. We will share more about new products, research collaborations, and improvements to the program in the coming months.

49
00:10:19.126 --> 00:10:37.114
That was Introducing the Life Sciences Verification Program, from Anthropic Newsroom, published September 17, 2026. Read the original at anthropic dot com. This unofficial audio edition was generated automatically for the podcast Anthropic, Read Aloud.